FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

UNICHEMLAB

333.65
-1.8 (-0.54%)
Updated 03:28 23/07 IST

UNICHEMLAB Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 5,055 for UNICHEMLAB
Disclaimer
100% Bullish
0% Bearish

UNICHEMLAB Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See UNICHEMLAB Share Price Targets >>

UNICHEMLAB Ratings

Long term UNICHEMLAB rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live UNICHEMLAB message board: Is UNICHEMLAB buy or sell? Should I buy UNICHEMLAB shares? Why are UNICHEMLAB shares falling? Should I invest in UNICHEMLAB stock?

  1. Home
  2. UNICHEMLAB Forum

UNICHEMLAB Share Price Discussion


#UNICHEMLAB : Co. informs tentative approval for ANDA from USFDA for Sitagliptin tablet USP , 25 Mg , 50 Mg & 100 Mg .of Merck Sharpe & Dohme corp
Like
Reply

Type
Buy
Instrument
UNICHEMLAB
Entry Price
₹352.5  ₹353.35
Price@Trade
₹353.15
Target Price
₹370
Stop Price
₹340
Valid Till
Jun 18, 2021 3:20 AM
Margin
₹70,670 approx for 200 Qty
Status
Target Achieved
Exit Price
₹370
Net P&L
+₹3,330 (+4.71%)
Like
Reply (3)
swap_vert
Trade
See all replies

Update
Entry Price Modified
Price @ Update
₹353.35
Original Entry Price
₹352.5
New Entry Price
₹353.35
TrackerBot @trackerbot
May 20 8:27 AM

Update
Trade Entered
Entry Price
₹353.35
TrackerBot @trackerbot
May 21 2:59 AM

Update
Target Achieved
Exit Price
₹370

Type
Buy
Instrument
UNICHEMLAB
Entry Price
₹335
Price@Trade
₹335.05
Target Price
₹342
Stop Price
₹333.95
Valid Till
May 4, 2021 3:20 AM
Margin
₹16,750 approx for 50 Qty
Status
Stoploss Hit
Exit Price
₹333.95
Net P&L
-₹52.5 (-0.31%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
May 4 4:04 AM

Update
Trade Entered
Entry Price
₹335
TrackerBot @trackerbot
May 4 4:19 AM

Update
Stoploss Hit
Exit Price
₹333.95

Type
Buy
Instrument
UNICHEMLAB
Entry Price
₹352
Price@Trade
₹351.25
Target Price
₹365
Stop Price
₹340
Valid Till
May 5, 2021 3:20 AM
Margin
₹999,680 approx for 2840 Qty
Status
Stoploss Hit
Exit Price
₹340
Net P&L
-₹34,080 (-3.41%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Apr 28 3:52 AM

Update
Trade Entered
Entry Price
₹352
TrackerBot @trackerbot
Apr 29 7:56 AM

Update
Stoploss Hit
Exit Price
₹340

Type
Buy
Instrument
UNICHEMLAB
Entry Price
₹341
Price@Trade
₹340.95
Target Price
₹348.4
Stop Price
₹339.8
Valid Till
Apr 22, 2021 3:20 AM
Margin
₹17,050 approx for 50 Qty
Status
Stoploss Hit
Exit Price
₹339.8
Net P&L
-₹60 (-0.35%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Apr 22 6:40 AM

Update
Trade Entered
Entry Price
₹341
TrackerBot @trackerbot
Apr 22 7:40 AM

Update
Stoploss Hit
Exit Price
₹339.8

Type
Sell
Instrument
UNICHEMLAB
Entry Price
₹348
Price@Trade
₹348.95
Target Price
₹341
Stop Price
₹355
Valid Till
Mar 5, 2021 3:20 AM
Margin
₹522,000 approx for 1500 Qty
Status
Exited
Exit Price
₹343.7
Net P&L
+₹6,450 (+1.24%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Mar 5 4:34 AM

Update
Trade Entered
Entry Price
₹348

Update
Exited
Exit Price
₹343.7
Net P&L
+₹6,450 (+1.24%)
T
Reputation: 35,645 • Mar 5 1:12 AM

Stocks in the news
Wipro: The company has signed an agreement to acquire Capco, a global management and technology consultancy providing digital, consulting and technology services to financial institutions in America, Europe and the Asia Pacific.
Heranba Industries: The company ...
Read more...
2
Reply
N
Reputation: 15,178 • Feb 19 10:03 AM
Unichem Laboratories Gets USFDA Nod For Plaque Psoriasis Treatment Drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Feb 19 10:03 AM
Unichem Laboratories Share Price Rises 8% On US FDA Approval For The Apremilast Tablets
The share touched a 52-week high of Rs 332.40 and a 52-week low of Rs 75.10 on 08 February 2021 and 24 March 2020, respectively.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Feb 19 5:26 AM
Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
The Economic Times
Like
Reply
N
Reputation: 15,178 • Jan 27 11:08 AM
Unichem Laboratories Gets USFDA Nod To Market Generic Capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Jan 27 10:01 AM
Unichem Labs gets USFDA nod to market generic capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
The Economic Times
Like
Reply
N
Reputation: 15,178 • Jan 13 7:58 AM
Unichem Laboratories Gets USFDA Nod To Market Generic Celecoxib Capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Jan 13 7:36 AM
Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
The Economic Times
Like
Reply
A
Reputation: 0 • Jan 8 3:24 AM

Type
Buy
Instrument
UNICHEMLAB
Entry Price
₹282.45
Price@Trade
₹282.45
Target Price
₹500
Stop Price
₹250
Valid Till
Jan 8, 2021 3:20 AM
Margin
₹84,735 approx for 300 Qty
Status
Validity Over
Exit Price
₹281.55
Net P&L
-₹270 (-0.32%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jan 8 8:50 AM

Update
Validity Over
Exit Price
₹281.55
Net P&L
-₹270 (-0.32%)
N
Reputation: 15,178 • Dec 1, 2020 3:48 AM
Unichem Laboratories shares rise 4% on USFDA approval for blood pressure tablets
The share touched its 52-week high Rs 304.20 and 52-week low Rs 75.10 on 04 August, 2020 and 24 March, 2020, respectively.
Moneycontrol
1
Reply
TradeAdda in UNICHEMLAB
#UNICHEMLAB For Educational Purposes only. #Tr...

UNICHEMLAB - 1595083
View Failed if bought still holding CLBS sl 229 and exit on Rise
#Update
For Educational Purposes only.
#TradeAdda
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • UNICHEMLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,369.98
    Enterprise Value1,178.95
    Price to Earnings0.79
    Price to Book Value0.5
    Return on Capital Employed0.93
    Return on Equity0.93
    Face Value2
    Dividend Yield0.02
  • UNICHEMLAB - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    24-Jan-17Karvy Stock BrokingBuy324
    24-Jan-17ICICIdirect.comHold285
    26-Oct-16KRChokseyAccumulate318
    25-Oct-16ICICIdirect.comHold305
    25-Oct-16Dolat CapitalBuy345
    UNICHEMLAB Brokerage Price Target
  • UNICHEMLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 23336.05344333333.9
    Jul 22333344333335.45
    Jul 20336.45340.15328332.1
    Jul 19333.8345331.95339.8
    Jul 16335.75339.75334.05336.6
  • UNICHEMLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹329.53
    30 Day Moving Average₹327.76
    50 Day Moving Average₹333.51
    100 Day Moving Average₹328.95
    200 Day Moving Average₹298.54
  • UNICHEMLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue6691,397.86-0.52
    Operating Profit-137161.95-1.85
    Profit Before Tax2,556131.618.42
    Net Income2,557103.8723.62
  • UNICHEMLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,7322,762-0.01
    Total Liabilities298368-0.19
    Total Assets3,0303,130-0.03
  • UNICHEMLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-66140.69-1.47
    Cash from Investing Activity1,649-132.52-13.44
    Cash from Financing Activity-930-8.95102.91
    Net Cash Flow653-0.78-838.18
  • UNICHEMLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.820.07
    Return on Equity0.930.09
    Return on Capital Employed0.930.12
  • UNICHEMLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.39
    3 Year CAGR Growth in Operating Profit-2.35
    3 Year CAGR Growth in EBIDTA20.43
    3 Year CAGR Growth in Net Income38.7
    3 Yr CAGR Growth - Diluted EPS50.27
  • UNICHEMLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.33
    5 Year CAGR Growth in Operating Profit-1.74
    5 Year CAGR Growth in EBIDTA12.04
    5 Year CAGR Growth in Net Income18.73
    3 Yr CAGR Growth - Diluted EPS24.36
  • UNICHEMLAB - Recent News

    keyboard_arrow_down
    NewsBot
    Feb 19 10:03 AM
    Unichem Laboratories Gets USFDA Nod For Plaque Psoriasis Treatment Drug
    Moneycontrol
    NewsBot
    Feb 19 10:03 AM
    Unichem Laboratories Share Price Rises 8% On US FDA Approval For The Apremilast Tablets
    Moneycontrol
    NewsBot
    Feb 19 5:26 AM
    Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug
    The Economic Times
    NewsBot
    Feb 2 4:18 AM
    NewsBot
    Feb 2 4:08 AM
    NewsBot
    Jan 27 11:08 AM
    Unichem Laboratories Gets USFDA Nod To Market Generic Capsules
    Moneycontrol
    NewsBot
    Jan 27 10:01 AM
    Unichem Labs gets USFDA nod to market generic capsules
    The Economic Times
    NewsBot
    Jan 13 7:58 AM
    Unichem Laboratories Gets USFDA Nod To Market Generic Celecoxib Capsules
    Moneycontrol
    NewsBot
    Jan 13 7:36 AM
    Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
    The Economic Times
    NewsBot
    Dec 1, 2020 3:48 AM
    Unichem Laboratories shares rise 4% on USFDA approval for blood pressure tablets
    Moneycontrol
  • UNICHEMLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020